The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas.
Cannabinoids represent unique compounds for treating tumors, including astrocytomas. Whether CB(1) and CB(2) receptors mediate this therapeutic effect is unclear.We generated astrocytoma subclones that express set levels of CB(1) and CB(2), and found that cannabinoids induce apoptosis only in cells...
Main Authors: | Eiron Cudaback, William Marrs, Thomas Moeller, Nephi Stella |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2806825?pdf=render |
Similar Items
-
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018-06-01) -
Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
by: Beatrice Polini, et al.
Published: (2020-12-01) -
Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B
by: Erhei Dai, et al.
Published: (2017-06-01) -
Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions
by: Eleftheria Lakiotaki, et al.
Published: (2015-01-01) -
Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys
by: Joseph Bouskila, et al.
Published: (2016-01-01)